Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Highlights •Melanoma tumors with loss of IFN-γ signaling lack response to ipilimumab •Cell lines that are resistant to IFN-γ in vitro have defective IFN-γ pathway •Mice